Clinical Trials Insight: 700033634
Phase of Trial: Phase I
Latest Information Update: 12 Mar 2009
At a glance
- Drugs TC 6499 (Primary)
- Indications Neuropathic pain
- Focus Adverse reactions
- Sponsors Targacept
- 12 Mar 2009 Status changed from planning to completed, based on a Targacept media release.
- 12 Mar 2009 Based on the results of this study, Targacept has discontinued development of TC 6499 for the treatment of neuropathic pain.
- 16 May 2008 New trial record.